FTS:TSXFortis Inc. Analysis
Data as of 2026-03-10 - not real-time
CA$78.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Fortis Inc. (FTS) is trading at C$78.72, comfortably above its 20‑day (C$77.51), 50‑day (C$74.32) and 200‑day (C$70.19) moving averages, indicating a bullish price trend. The RSI sits at 66.8, signaling an overbought condition that could temper short‑term upside, while the MACD histogram is slightly negative (-0.08) and the signal line is bearish, suggesting a potential near‑term pause. The stock enjoys a solid dividend yield of 3.23% and has just extended a 52‑year streak of dividend increases, reinforcing its appeal to income investors. However, valuation metrics are stretched: the forward P/E of 20.4 exceeds the industry average of 20.86, and the DCF‑derived fair value of C$26.06 is far below the current price, pointing to an overvalued market level.
Fundamentally, Fortis delivers stable earnings with a profit margin of 14.8% and a ROE of 7.6%, but its balance sheet is heavily leveraged (debt‑to‑equity ~134) and free cash flow is negative (≈‑C$2.6 B). The high payout ratio of 73% combined with limited cash generation raises questions about dividend sustainability in a rising‑rate environment. Nonetheless, the regulated utility business provides predictable cash flows and low sector volatility, supporting a long‑term investment case if the stock price corrects toward intrinsic values.
Fundamentally, Fortis delivers stable earnings with a profit margin of 14.8% and a ROE of 7.6%, but its balance sheet is heavily leveraged (debt‑to‑equity ~134) and free cash flow is negative (≈‑C$2.6 B). The high payout ratio of 73% combined with limited cash generation raises questions about dividend sustainability in a rising‑rate environment. Nonetheless, the regulated utility business provides predictable cash flows and low sector volatility, supporting a long‑term investment case if the stock price corrects toward intrinsic values.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance at C$79.05
- Overbought RSI and bearish MACD signal
- High valuation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained dividend growth and 3.23% yield
- Elevated leverage and negative free cash flow
- Stable regulated earnings supporting cash flow
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- 52‑year dividend increase streak
- Low sector volatility and predictable cash flows
- Potential price correction toward intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth4.40%
Profit Margin14.78%
P/E Ratio23.2
ROE7.58%
ROA3.01%
Debt/Equity134.11
P/B Ratio1.8
Op. Cash FlowCA$4.1B
Free Cash FlowCA$-2633250048
Industry P/E20.9
Technical Analysis
TrendBullish
RSI66.8
SupportCA$73.25
ResistanceCA$79.05
MA 20CA$77.51
MA 50CA$74.32
MA 200CA$70.19
MACDBearish
VolumeStable
Fear & Greed Index81.02
Valuation
Fair ValueCA$26.06
Target PriceCA$75.50
Upside/Downside-4.09%
GradeOvervalued
TypeValue
Dividend Yield3.23%
Risk Assessment
Beta-0.14
Volatility16.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.